OBJECTIVES: A multicenter prospective study was performed to assess the results and risks associated with radiofrequency ablation in children. This report focuses on recurrences following initially successful ablation. METHODS: Patients recruited for the study were aged 0 to 16 years and had supraventricular tachycardia due to accessory pathways or atrioventricular nodal reentrant tachycardia (AVNRT), excluding patients with more than trivial congenital heart disease. A total of 481 patients were recruited into the prospective cohort and were followed at 2, 6, and 12 months following ablation. RESULTS: There were 517 successfully ablated substrates out of 540 attempted (95.7%). Loss to follow-up for individual substrates was 3.3%, 10.6%, and 21.2% at 2, 6, and 12 months, respectively. Recurrence was observed in 7.0%, 9.2%, and 10.7% of these substrates at 2, 6, and 12 months, respectively (adjusted for loss to follow-up as an independent source of data censoring). Recurrence rate varied by substrate location (24.6% for right septal, 15.8% for right free wall, 9.3% for left free wall, and 4.8% for left septal), as well as for AVNRT versus all others (4.8% vs 12.9%) at 12 months. The recurrence rate was higher for substrates ablated using power control but was not a function of whether isoproterenol was used for postablation testing. CONCLUSIONS: Recurrence after initially successful ablation occurs commonly in children. It is least common after AVNRT ablation and most common following ablation of right-sided pathways. These results serve as a benchmark for the time course of recurrence following initially successful ablation of supraventricular tachycardia in children.
OBJECTIVES: A multicenter prospective study was performed to assess the results and risks associated with radiofrequency ablation in children. This report focuses on recurrences following initially successful ablation. METHODS:Patients recruited for the study were aged 0 to 16 years and had supraventricular tachycardia due to accessory pathways or atrioventricular nodal reentrant tachycardia (AVNRT), excluding patients with more than trivial congenital heart disease. A total of 481 patients were recruited into the prospective cohort and were followed at 2, 6, and 12 months following ablation. RESULTS: There were 517 successfully ablated substrates out of 540 attempted (95.7%). Loss to follow-up for individual substrates was 3.3%, 10.6%, and 21.2% at 2, 6, and 12 months, respectively. Recurrence was observed in 7.0%, 9.2%, and 10.7% of these substrates at 2, 6, and 12 months, respectively (adjusted for loss to follow-up as an independent source of data censoring). Recurrence rate varied by substrate location (24.6% for right septal, 15.8% for right free wall, 9.3% for left free wall, and 4.8% for left septal), as well as for AVNRT versus all others (4.8% vs 12.9%) at 12 months. The recurrence rate was higher for substrates ablated using power control but was not a function of whether isoproterenol was used for postablation testing. CONCLUSIONS: Recurrence after initially successful ablation occurs commonly in children. It is least common after AVNRT ablation and most common following ablation of right-sided pathways. These results serve as a benchmark for the time course of recurrence following initially successful ablation of supraventricular tachycardia in children.
Authors: Luz-Maria Rodriguez; J Christoph Geller; Hung-Fat Tse; Carl Timmermans; Sven Reek; Kathy Lai-fun Lee; Gregory M Ayers; Chu-Pak Lau; Helmut U Klein; Harry J G M Crijns Journal: J Cardiovasc Electrophysiol Date: 2002-11
Authors: George F Van Hare; Dorit Carmelli; W Mcfate Smith; John Kugler; Michael Silka; Richard Friedman; Dianne Atkins; Philip Saul; Michael Schaffer; Craig Byrum; Ann Dunnigan; Steven Colan; Gerald Serwer Journal: Pacing Clin Electrophysiol Date: 2002-03 Impact factor: 1.976
Authors: Marta Telishevska; J Hebe; T Paul; J H Nürnberg; U Krause; R Gebauer; M Gass; C Balmer; F Berger; S Molatta; M Emmel; W Lawrenz; T Kriebel; G Hessling Journal: Clin Res Cardiol Date: 2018-12-05 Impact factor: 5.460
Authors: Ari J Gartenberg; Robert H Pass; Scott Ceresnak; Lynn Nappo; Christopher M Janson Journal: Pediatr Cardiol Date: 2018-10-12 Impact factor: 1.655
Authors: George F Van Hare; Steven D Colan; Harold Javitz; Dorit Carmelli; Timothy Knilans; Michael Schaffer; John Kugler; Craig J Byrum; J Philip Saul Journal: Am Heart J Date: 2007-05 Impact factor: 4.749
Authors: Henrike Siebels; Christian Sohns; Jan-Hendrik Nürnberg; Jürgen Siebels; Klaus Langes; Joachim Hebe Journal: J Interv Card Electrophysiol Date: 2018-05-15 Impact factor: 1.900
Authors: Béatrice Brembilla-Perrot; A Moulin-Zinsch; J M Sellal; J Schwartz; A Olivier; P Y Zinzius; C De Chillou; D Beurrier; M Rodermann; G Goudote; H Al Amoura; A Terrier de la Chaise; J Lemoine; J Rizk; J P Lethor; J L Anne Tisserand; S Taïhi; F Marçon Journal: Pediatr Cardiol Date: 2013-04-23 Impact factor: 1.655